Altravax, Inc. today announced the appointment of Dr. Sean X. Du to the role of Chief Operating Officer. He joins Altravax from Simcere Pharmaceuticals Group (NYSE:SCR) where he was Executive Director, Institute of Vaccine Research. Dr. Du established Simcere’s R&D capabilities for new generation vaccines and was also involved in the evaluation of vaccine-related collaborations and M&A opportunities. He led preclinical development of both a therapeutic hepatitis B vaccine and Vero-cell-based rabies vaccine, with the later program achieving a clinical filing to the Chinese SFDA.
Help employers find you! Check out all the jobs and post your resume.
